{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T03:40:01Z","timestamp":1756525201152,"version":"3.44.0"},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,7,25]]},"DOI":"10.1253\/circj.cj-24-0589","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T17:14:11Z","timestamp":1741022051000},"page":"1113-1120","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stents in Percutaneous Coronary Intervention for Hemodialysis Patients"],"prefix":"10.1253","volume":"89","author":[{"given":"Narumi","family":"Taninobu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoki","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nishiura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Mushiake","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ikuta","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Osakada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Sawayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Fuku","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazusige","family":"Kadota","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shimizu A, Sonoda S, Muraoka Y, Setoyama K, Inoue K, Miura T, et al. Bleeding and ischemic events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients. <i>J Cardiol<\/i> 2019; 73: 470\u2013478.","DOI":"10.1016\/j.jjcc.2018.12.009"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. <i>Clin J Am Soc Nephrol<\/i> 2007; 2: 1241\u20131248.","DOI":"10.2215\/CJN.02190507"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kurihara K, Ashikaga T, Sasaoka T, Yoshikawa S, Isobe M; Tokyo-MD PCI Study Investigators. Incidence and predictors of early and late target lesion revascularization after everolimus-eluting stent implantation in unselected patients in Japan. <i>Catheter Cardiovasc Interv<\/i> 2017; 90: 78\u201386.","DOI":"10.1002\/ccd.26964"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Taglieri N, Bruno AG, Ghetti G, Marrozzini C, Saia F, Gali\u00e9 N, et al. target lesion failure with current drug-eluting stents: Evidence from a comprehensive network meta-analysis. <i>JACC Cardiovasc Interv<\/i> 2020; 13: 2868\u20132878.","DOI":"10.1016\/j.jcin.2020.09.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, et al.; BIOFLOW V Investigators. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularization (BIOFLOW V): A randomized trial. <i>Lancet<\/i> 2017; 390: 1843\u20131852.","DOI":"10.1016\/S0140-6736(17)32249-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, et al. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): A single-blind, prospective, randomized superiority trial. <i>Lancet<\/i> 2019; 394: 1243\u20131253.","DOI":"10.1016\/S0140-6736(19)31877-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 Guideline focused update on antithrombotic therapy in patients with coronary artery disease. <i>Circ J<\/i> 2020; 84: 831\u2013865.","DOI":"10.1253\/circj.CJ-19-1109"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Choi KH, Park YH, Song YB, Park TK, Lee JM, Yang JH, et al.; SMART-CHOICE Investigators. Long-term effects of P2Y12 inhibitor monotherapy after percutaneous coronary intervention: 3-year follow-up of the SMART-CHOICE randomized clinical trial. <i>JAMA Cardiol<\/i> 2022; 7: 1100\u20131108.","DOI":"10.1001\/jamacardio.2022.3203"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al.; Society for Cardiovascular Angiography and Interventions. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). <i>Catheter Cardiovasc Interv<\/i> 2014; 83: 27\u201336.","DOI":"10.1002\/ccd.25135"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al.; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. <i>Circulation<\/i> 2007 115: 2344\u20132351.","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese Association of Cardiovascular Intervention and Therapeutics. <i>Cardiovasc Interv Ther<\/i> 2020; 35: 105\u2013116.","DOI":"10.1007\/s12928-020-00653-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee JB, Mintz GS, Lisauskas JB, Biro SG, Pu J, Sum ST, et al. Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules. <i>Am J Cardiol<\/i> 2011 108: 1547\u20131551.","DOI":"10.1016\/j.amjcard.2011.07.014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. <i>J Am Coll Cardiol<\/i> 2013 62: 1748\u20131758.","DOI":"10.1016\/j.jacc.2013.05.071"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Leone A, Simonetti F, Avvedimento M, Angellotti D, Immobile Molaro M, Franzone A, et al. Ultrathin struts drug-eluting stents: A State-of-the-Art Review. <i>J Pers Med<\/i> 2022; 12: 1378.","DOI":"10.3390\/jpm12091378"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, et al. Two-year clinical outcomes of biodegradable polymer vs. durable polymer drug-eluting stent implantation in patients with end-stage renal disease on dialysis. <i>Circ Rep<\/i> 2020; 3: 18\u201325.","DOI":"10.1253\/circrep.CR-20-0120"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ito R, Ishii H, Oshima S, Nakayama T, Sakakibara T, Kakuno M, et al. Comparison between biodegradable- and durable-polymer everolimus-eluting stents in hemodialysis patients with coronary artery disease. <i>Cardiovasc Interv Ther<\/i> 2022 37: 475\u2013482.","DOI":"10.1007\/s12928-021-00827-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sugita H, Motohiro M, Morishita S, Tanaka M, Tsujimoto S, Shiojima I. Factors associated with coronary in-stent restenosis after drug-eluting stent implantation in patients on chronic hemodialysis. <i>Blood Purif<\/i> 2022 51: 383\u2013389.","DOI":"10.1159\/000517279"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nakamura N, Torii S, Tsuchiya H, Nakano A, Oikawa Y, Yajima J, et al. Formation of calcified nodule as a cause of early in-stent restenosis in patients undergoing dialysis. <i>J Am Heart Assoc<\/i> 2020 9: e016595.","DOI":"10.1161\/JAHA.120.016595"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gritters M, Borgdorff P, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, et al. Platelet activation in clinical hemodialysis: LMWH as a major contributor to bio-incompatibility. <i>Nephrol Dial Transplant<\/i> 2008 23: 2911\u20132917.","DOI":"10.1093\/ndt\/gfn137"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Konishi A, Shinke T, Otake H, Nakatani D, Nakagawa M, Inoue T, et al. Impact of hemodialysis on local vessel healing and thrombus formation after drug-eluting stent implantation. <i>J Cardiol<\/i> 2014 64: 25\u201331.","DOI":"10.1016\/j.jjcc.2013.10.020"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pilgrim T, Heg D, Roffi M, T\u00fcller D, Muller O, Vuilliomenet A, et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): A randomised, single-blind, non-inferiority trial. <i>Lancet<\/i> 2014; 384: 2111\u20132122.","DOI":"10.1016\/S0140-6736(14)61038-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Torii S, Jinnouchi H, Sakamoto A, Mori H, Park J, Amoa FC, et al. Vascular responses to coronary calcification following implantation of newer-generation drug-eluting stents in humans: Impact on healing. <i>Eur Heart J<\/i> 2020 41: 786\u2013796.","DOI":"10.1093\/eurheartj\/ehz850"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ino Y, Takahata M, Kubo T, Khalifa AKM, Satogami K, Terada K, et al. Vascular response after everolimus-eluting stent in acute myocardial infarction caused by calcified nodule. <i>Circ J<\/i> 2022 86: 1388\u20131396.","DOI":"10.1253\/circj.CJ-21-1059"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ogura K, Tsujita H, Oishi Y, Matsumoto H, Matsukawa N, Sakai R, et al. Early vascular healing following bioresorbable-polymer sirolimus-eluting stent placement compared to that with durable-polymer everolimus-eluting stent. <i>Int Heart J<\/i> 2021 62: 510\u2013519.","DOI":"10.1536\/ihj.20-627"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pache J, Kastrati A, Mehilli J, Sch\u00fchlen H, Dotzer F, Hausleiter J, et al. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. <i>J Am Coll Cardiol<\/i> 2003 41: 1283\u20131288.","DOI":"10.1016\/S0735-1097(03)00119-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Dan K, Garcia-Garcia HM, Kolm P, Windecker S, Saito S, Kandzari DE, et al. Comparison of ultrathin, bioresorbable-polymer sirolimus-eluting stents and thin, durable-polymer everolimus-eluting stents in calcified or small vessel lesions. <i>Circ Cardiovasc Interv<\/i> 2020 13: e009189.","DOI":"10.1161\/CIRCINTERVENTIONS.120.009189"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ito R, Ishii H, Oshima S, Nakayama T, Sakakibara T, Kakuno M, et al. Comparison between biodegradable- and durable-polymer everolimus-eluting stents in hemodialysis patients with coronary artery disease. <i>Cardiovasc Interv Ther<\/i> 2022 37: 475\u2013482.","DOI":"10.1007\/s12928-021-00827-x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yano H, Horinaka S, Yagi H, Ishimitsu T. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. <i>Heart Vessels<\/i> 2013; 28: 308\u2013315.","DOI":"10.1007\/s00380-012-0250-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ann SH, Seo SM, Kim PJ, Koh YS, Her SH, Shin DI, et al. Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes. <i>Cardiol J<\/i> 2016 23: 637\u2013646.","DOI":"10.5603\/CJ.a2016.0065"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Makino A, Saito Y, et al. Stratification analysis of statin effect on major adverse cardiac events after percutaneous coronary intervention in patients on hemodialysis. <i>J Cardiovasc Pharmacol<\/i> 2022 79: 168\u2013176.","DOI":"10.1097\/FJC.0000000000001152"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/8\/89_CJ-24-0589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T03:25:42Z","timestamp":1756524342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/8\/89_CJ-24-0589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0589","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"type":"print","value":"1346-9843"},{"type":"electronic","value":"1347-4820"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"CJ-24-0589"}}